RITTER DALE 4
4 · INOTEK PHARMACEUTICALS CORP · Filed Sep 18, 2017
Insider Transaction Report
Form 4
RITTER DALE
Vice President, Finance
Transactions
- Exercise/Conversion
Common Stock
2017-09-14+12,500→ 19,827 total - Exercise/Conversion
Restricted Stock Units
2017-01-17−12,500→ 37,500 total→ Common Stock (12,500 underlying)
Footnotes (4)
- [F1]Includes 7,327 shares of ITEK's common stock acquired under ITEK's Employee Stock Purchase Plan since the date of the Reporting Person's last Form 4 with Table I information. Of these 7,237 shares of ITEK's common stock, 2,591 shares were acquired on November 30, 2015 at the price of $4.83, 782 shares were acquired on May 31, 2016 at the price of $7.82, 1,765 shares were acquired on November 30, 2016 at the price of $5.44 and 2,189 shares were acquired on May 31, 2017 at the price of $1.45.
- [F2]On September 14, 2017, 12,500 shares of Common Stock were issued in settlement of the restricted stock units described in footnote (4) below.
- [F3]Each restricted stock unit represents a contingent right to receive one share of ITEK common stock.
- [F4]The restricted stock units were issued pursuant to Inotek Pharmaceuticals Corporation's 2014 Stock Option and Incentive Plan (the "Plan"). The restricted stock units vest in equal 25% tranches every 6 months over a 2 year period from the date of grant, subject to continued service through such dates.